p53-mutated GBM cells are less sensitive to TMZ than wild-type cells through the Bcl-2/caspase pathway, whereas p53 wild-type cells trigger the death receptor pathway by induction of the Fas receptor [46]. Here, TP53 is linked to glioblastoma.